RAD51 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.858600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.261200E-01
Normal-vs-Stage2
5.100800E-01
Normal-vs-Stage3
9.014000E-01
Normal-vs-Stage4
7.944200E-01
Stage1-vs-Stage2
4.425800E-01
Stage1-vs-Stage3
8.424200E-01
Stage1-vs-Stage4
7.678400E-01
Stage2-vs-Stage3
3.801000E-01
Stage2-vs-Stage4
3.232600E-01
Stage3-vs-Stage4
9.088800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.799000E-01
Normal-vs-AfricanAmerican
7.940200E-01
Normal-vs-Asian
3.481000E-01
Caucasian-vs-AfricanAmerican
2.864400E-01
Caucasian-vs-Asian
6.170400E-01
AfricanAmerican-vs-Asian
1.444580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.683800E-01
Normal-vs-Female
5.086600E-01
Male-vs-Female
2.583800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.067000E-01
Normal-vs-Age(41-60Yrs)
5.371000E-01
Normal-vs-Age(61-80Yrs)
6.208400E-01
Normal-vs-Age(81-100Yrs)
4.397600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.781400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.775400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.969360E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.700400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.178000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.872200E-01
Normal-vs-Daily Drinker
4.674000E-01
Normal-vs-Weekly Drinker
5.013200E-01
Normal-vs-Occasional Drinker
5.468800E-01
Normal-vs-Social Drinker
7.259000E-01
Non Drinker-vs-Daily Drinker
8.170200E-01
Non Drinker-vs-Weekly Drinker
8.270000E-01
Non Drinker-vs-Occasional Drinker
9.993000E-01
Non Drinker-vs-Social Drinker
5.004800E-01
Daily Drinker-vs-Weekly Drinker
9.795200E-01
Daily Drinker-vs-Occasional Drinker
8.240400E-01
Daily Drinker-vs-Social Drinker
3.380800E-01
Weekly Drinker-vs-Occasional Drinker
8.296200E-01
Weekly Drinker-vs-Social Drinker
3.812000E-01
Occasional Drinker-vs-Social Drinker
4.822600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.147000E-01
Normal-vs-Grade 2
7.192600E-01
Normal-vs-Grade 3
7.692400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.620500E-04
Grade 1-vs-Grade 3
4.181600E-04
Grade 1-vs-Grade 4
6.147000E-01
Grade 2-vs-Grade 3
2.193000E-01
Grade 2-vs-Grade 4
7.192600E-01
Grade 3-vs-Grade 4
7.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.373400E-01
Normal-vs-NonDiabetic
5.119000E-01
Diabetic-vs-NonDiabetic
4.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.595800E-02
Normal-vs-NoPancreatitis
6.110800E-01
Pancreatitis-vs-NoPancreatitis
8.777800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.067200E-01
Normal-vs-N1
5.345400E-01
N0-vs-N1
6.511600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.322570E-01
Normal-vs-TP53-NonMutant
8.623400E-01
TP53-Mutant-vs-TP53-NonMutant
1.5340000003583E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
